Pfizer Earnings
NYSE: PFEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:01 PM ET · Delayed 15 min
Next earnings date
Tue, Nov 3, 2026
Before market open
Fiscal period
Sep/2026
EPS estimate
$0.75
Pfizer earnings summary
Pfizer is scheduled to report Sep/2026 earnings on Nov 3, 2026 before the market opens, with analysts expecting EPS of $0.75. In its most recent report on Aug 4, 2026 (Q2 2026), PFE posted EPS of $-0.04. Revenue for the quarter was $15.03 billion.
Quarterly EPS is down 107.8% from the same quarter a year earlier. Across the last 16 reports, PFE shares moved an average of 2.1% (in either direction) in the first trading session after results, rising 9 times and falling 7 times.
Summary generated from market data by MetaCap's automated system. Methodology
PFE earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 4, 2026 | — | $-0.04 | — | +0.1% |
| May 5, 2026 | — | $0.47 | — | -1.4% |
| Feb 26, 2026 | — | $-0.29 | — | -2.2% |
| Nov 4, 2025 | — | $0.62 | — | +2.6% |
| Aug 5, 2025 | — | $0.51 | — | +2.3% |
| May 5, 2025 | — | $0.52 | — | +2.5% |
| Feb 27, 2025 | — | $0.07 | — | +1.1% |
| Nov 4, 2024 | — | $0.78 | — | -7.2% |
| Aug 5, 2024 | — | $0.01 | — | -0.9% |
| May 8, 2024 | — | $0.55 | — | +2.2% |
| Feb 22, 2024 | — | $-0.59 | — | -4.2% |
| Nov 8, 2023 | — | $-0.42 | — | +1.5% |
| Aug 9, 2023 | — | $0.41 | — | +1.7% |
| May 10, 2023 | — | $0.97 | — | -1.6% |
| Feb 23, 2023 | — | $0.86 | — | -1.4% |
| Nov 9, 2022 | — | $1.51 | — | +1.3% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.